The 16 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 75.00, with a high estimate of 88.00 and a low estimate of 64.00. The median estimate represents a +21.40% increase from the last price of 61.78.
The current consensus among 20 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.40
Reporting Date Jan 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.